FDA Inspection
Carter BloodCare at HulenCarter BloodCare at Hulen – FDA Inspection, Aug 30, 2010
Record Details
This FDA Inspection record concerns Carter BloodCare at Hulen, with an inspection on August 30, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Carter BloodCare at Hulen
- Inspection Date
- August 30, 2010
- Product Type
- Biologics
View Company Profile
ID · 95cced15-c453-4183-8abf-af0e5ab3ad91
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 677578
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(b)(9)Written methods for investigating adverse reactions
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carter BloodCare at Hulen
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2026 | Not classified | Dallas District Office | |
| October 28, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 13, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 9, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 3, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare at Hulen
- FDA Inspection 1317894 - 2026-04-09
- FDA Inspection 1187284 - 2022-10-28
- FDA Inspection 1049593 - 2018-04-13
- FDA Inspection 985181 - 2016-09-09
- FDA Inspection 881450 - 2014-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.